S
ORIC icon

SignatureFD’s Oric Pharmaceuticals ORIC Stock Holding History

SignatureFD’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05K Hold
83
– – ﹤0.01% 3200
2025
Q4 		$679 Hold
83
– – ﹤0.01% 3178
2025
Q3 		$996 Hold
83
– – ﹤0.01% 3090
2025
Q2 		$842 Sell
83
-153
-65% -$1.03K ﹤0.01% 3047
2025
Q1 		$1.32K Hold
236
– – ﹤0.01% 2985
2024
Q4 		$1.91K Sell
236
-39
-14% -$358 ﹤0.01% 2888
2024
Q3 		$2.82K Buy
275
+39
+17% +$386 ﹤0.01% 2733
2024
Q2 		$1.67K Sell
236
-38
-14% -$340 ﹤0.01% 2802
2024
Q1 		$3.77K Hold
274
– – ﹤0.01% 2624
2023
Q4 		$2.52K Buy
+274
New +$1.98K ﹤0.01% 2706
2022
Q2 		– Sell
-22
Closed – – 3285
2022
Q1 		$0 Sell
22
-14
-39% -$126 ﹤0.01% 3272
2021
Q4 		$1K Sell
36
-44
-55% -$686 ﹤0.01% 2966
2021
Q3 		$2K Buy
+80
New +$1.62K ﹤0.01% 2687

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

SignatureFD's ORIC Position: Q1 2026 in Review

SignatureFD held its Oric Pharmaceuticals (ORIC) position steady in Q1 2026 at 83 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #3200.

SignatureFD first reported a position in ORIC in Q3 2021 and has held it in 13 quarters since. The position peaked at $3.77K in Q1 2024. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • SignatureFD held 83 shares of Oric Pharmaceuticals worth $1.05K as of Q1 2026.
  • SignatureFD left its Oric Pharmaceuticals share count unchanged in Q1 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #3200 holding.
  • SignatureFD first reported a position in Oric Pharmaceuticals in Q3 2021 and has held it in 13 quarters since.
  • SignatureFD's Oric Pharmaceuticals position peaked at $3.77K in Q1 2024.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.